| Authors: |
Faro EZ; Albert Einstein College of Medicine, Bronx, NY, USA.; 37292 Children's Hospital at Montefiore, Bronx, NY, USA., Shook L; 2518 Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Cincinnati Comprehensive Sickle Cell Center, Cincinnati, OH, USA., Treadwell MJ; 6164 Department of Hematology/Oncology, UCSF Benioff Children's Hospital Oakland, Oakland, CA, USA., King AA; 12275 Washington University School of Medicine, St Louis, MO, USA., Whiteman LN; 116031 Washington/Baltimore High Intensity Drug Trafficking Areas Program, George Mason University, Fairfax, VA, USA., Ivy ED; 374349 Hemoglobinopathies Programs, Genetic Services Branch, Division of Services for Children With Special Health Needs, Maternal and Child Health Bureau, Health Resources and Services Administration, Washington, DC, USA., Hulihan M; 1242 Epidemiology and Surveillance Branch, Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA., Kavanagh PL; 12259 Department of Pediatrics, Boston University School of Medicine, Boston, MA, USA.; Pediatric Emergency Department, Boston Medical Center, Boston, MA, USA., Selk S; 1854 Office of Health Equity, Massachusetts Department of Public Health, Boston, MA, USA., Oyeku S; Albert Einstein College of Medicine, Bronx, NY, USA.; 37292 Children's Hospital at Montefiore, Bronx, NY, USA., Berns SD; 50980 National Institute for Children's Health Quality, Boston, MA, USA.; Warren Alpert Medical School of Brown University, Providence, RI, USA.; Brown University School of Public Health, Providence, RI, USA. |
